A preliminary study of inflammatory markers in non-alcoholic steatohepatitis patients

Libyan Journal of Medicine

Volumn 5, Issue 1, 2010, Pages 1-4

  Priya, Manopriya T ^a   Sheriff, Dhastagir Sultan ^b  

^a Institute of Research in Science and Medicine   (India)

^b AL ARAB MEDICAL UNIVERSITY   (Libyan Arab Jamahiriya)

Author keywords

Alpha 1 anti trypsin; Alpha 2 macroglobulin; Alpha 1 acid glycoprotein; C reactive protein; Coronary artery disease; Lipoprotein a; Non alcoholic steatohepatitis

Indexed keywords

ALPHA 2 MACROGLOBULIN; C REACTIVE PROTEIN; CERULOPLASMIN; FERRITIN;

ADULT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; HUMAN; HYPERTENSION; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; PROTEIN BLOOD LEVEL;

EID: 77951183828     PISSN: 19932820     EISSN: 18196357     Source Type: Journal    
DOI: 10.3402/ljm.v5i0.5071     Document Type: Article

References (13)

1. Neuschwander-Tetri BA. Evolving pathophysiologic concepts in non-alcoholic steatohepatitis. Curr Gastroenterol Rep. 2002; 4: 31-6.
2. Gupta S, Slaughter S, Akriviadis EA, Valenzuela R, Deodhar SD. Serial measurement of serum C-reactive protein facilitates evaluation in alcoholic hepatitis. Hepatogastroenterology 1995; 42: 516-21.
3. Shiota G, Umeki K, Okano J, Kawasaki H. Hepatocyte growth factor and acute phase proteins in patients with chronic liver diseases. J Med. 1995; 26: 295-308.
4. Shima M, Nakao K, Kato Y, Nakata K, Ishii N, Nagataki S. Comparative study of C-reactive protein in chronic hepatitis B and chronic hepatitis C. Tohoku J Exp Med. 1996; 178: 287-97.
5. Bell H, Skinningsrud A, Raknerud N, Try K. Serum ferritin and transferrin saturation in patients with chronic alcoholic and non-alcoholic liver disease. J Intern Med. 1994; 236: 315-22.
6. Bacon B, Farahvash M, Janney C, Neuschwander-Tetri B. Non-alcoholic steatohepatitis: an expanded clinical entity. Gastroenterology 1994; 107: 1103-9.
7. George DK, Goldwurm S, McDonald GA, Cowley LL, Walker NI, Ward PJ, et al. Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis. Gastroenterology 1998; 114: 311-8.
8. Moirand R, Mortaji AM, Loreal O, Paillard F, Brissot P, Deugnier Y. A new syndrome of liver iron overload with normal transferrin saturation. Lancet 1997; 349: 95-7.
9. Mendler MH, Turlin B, Moirand R, Jouanolle A-M, Sapey T, Guyader D, et al. Insulin resistance-associated hepatic iron overload. Gastroenterology 1999; 117: 1155-63.
10. Fargion S, Mattioli M, Fracanzani AL, Sampietro M, Tavazzi D, Fociani P, et al. Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for non-alcoholic steatohepatitis. Am J Gastroenterol. 2001; 96: 2448-54.
11. Gerok W, Gross V. Protein secretion, degradation and function. In: Bircher J, Benhamou JP, Mclntyre N, Rizetto M, Rodes J, editors. Oxford textbook of clinical hepatology. 2nd ed., vol. 1. New York: Oxford University Press; 1999, p. 346-67.
12. Tuck CH, Holleran S, Berglund L. Hormonal regulation of lipoprotein(a) levels: effects of estrogen replacement therapy on lipoprotein (a) and acute phase reactants in postmenopausal women. Arterioscler Thromb Biol. 1997; 17: 1822-9.
13. Min WK, Chun S, Hwang SH, Park H. No relationship between serum lipoprotein(a) and albumin concentrations in patients with acute phase response. Ann Clin Biochem. 1999; 36: 617-21.